AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle ...
AUSTIN, Texas--(BUSINESS WIRE)--Alafair Biosciences Inc., an emerging medical device company, announced today that it received 510(k) clearance from the FDA to market and sell its tendon product, ...
AUSTIN, Texas, Nov. 21, 2023 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that surgeons have implanted over 12,000 units of its flagship product, ...
AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- Alafair Biosciences announced today that VersaWrap has received 510(k) clearance from the FDA, enabling application of VersaWrap in all populations, ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas, July 30, 2025 /PRNewswire/ -- Alafair Biosciences, a medical device company redefining soft-tissue ...
VersaWrap is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA) and alginate that provides a gelatinous encasement for peripheral nerves, tendons, and surrounding ...
(MENAFN- PR Newswire) This B.R.A.A.D study, which stands for "Better Recovery, Hyaluronic Acid (HA) and Alginate Device" represents Alafair's commitment to improving surgical outcomes and reducing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results